Kaisa Health Swings to Interim Loss as Revenue and Margins WeakenTip Ranks·1 day ago, 10:16 AM00876-2.37%
Kaisa Health FY26 H1 net loss widens to HK$ 62.48 million; revenue falls to HK$ 284.59 millionPUBT·1 day ago, 09:41 AM00876-2.37%
Kaisa Health expects H1 loss attributable to owners up to HK$65 millionPUBT·Aug 19 at 07:05 AM00876-2.37%
Kaisa Health Group board to review interim results, consider dividendPUBT·Aug 13 at 06:09 AM00876-2.37%
Kaisa Health postpones special shareholder meeting to Sept. 1 from Aug. 18PUBT·Aug 12 at 06:29 AM00876-2.37%
Hong Kong's Fragmented Signals: From Property Defense to Tech Capital RaisingsGlobal Report·Aug 11 at 04:43 AM06098-1.17%02575+2.09%
Kaisa Health Group shifts Bermuda registered office to Richmond House from Aug. 3, 2026PUBT·Aug 7 at 09:59 AM00876-2.37%
Kaisa Health Plans Biotech-Focused Name Change After AcquisitionTip Ranks·Aug 6 at 10:11 AM00876-2.37%
Kaisa Health proposes renaming to Qinghai Biotech Pharmaceutical GroupPUBT·Aug 6 at 09:45 AM00876-2.37%
Kaisa Health proposes rebrand to Qinghai Pharmaceutical GroupPUBT·Jul 15 at 05:53 AM00876-2.37%029540.00%
